RT Journal Article
SR Electronic
T1 Cross-site predictions of readmission after psychiatric hospitalization with mood or psychotic disorders
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.08.26.24312586
DO 10.1101/2024.08.26.24312586
A1 Ren, Boyu
A1 Yoon, WonJin
A1 Thomas, Spencer
A1 Savova, Guergana
A1 Miller, Timothy
A1 Hall, Mei-Hua
YR 2024
UL http://medrxiv.org/content/early/2024/08/26/2024.08.26.24312586.abstract
AB Patients with mood or psychotic disorders have high rates of unplanned readmission, and predicting readmission likelihood may guide discharge decisions. In this retrospective, multi-site study, we assess the predictive power of various structured variables from electronic health records for all-cause readmission in each site separately and evaluate the generalizability of the in-site prediction models across sites. We find that the set of relevant predictors vary significantly across. For example, length of stay is strongly predictive of readmission at only three out of the four sites. We also find a general lack of cross-site generalizability of the in-site prediction models, with in-site predictions having an average F1 score of 0.666, compared to an average F1 score of 0.551 for cross-site predictions. The generalizability cannot be improved even after adjusting for differences in the distributions of predictors. These results indicate that, with this set of predictors, fitting individual models at each site is necessary to achieve reasonable prediction accuracy. Additionally, they suggest that more sophisticated predictors variables or predictive algorithms are needed to develop generalizable models capable of extracting robust insights into the root causes of early psychiatric readmissions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by NIH (grant number: R01MH126977).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of Mass General Brigham gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data is not publicly available.